WallStreetZenWallStreetZen

NASDAQ: INSM
Insmed Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for INSM

Based on 18 analysts offering 12 month price targets for Insmed Inc

Min Forecast
$160.00+63.52%
Avg Forecast
$212.89+117.57%
Max Forecast
$245.00+150.38%

Should I buy or sell INSM stock?

Based on 18 analysts offering ratings for Insmed Inc.

Strong Buy
Strong Buy
14 analysts 77.78%
Buy
4 analysts 22.22%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although INSM's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates INSM as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their INSM stock forecasts and price targets.

INSM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-06-08
lockedlocked$00.00+00.00%2026-06-05
lockedlocked$00.00+00.00%2026-05-14
lockedlocked$00.00+00.00%2026-05-08
lockedlocked$00.00+00.00%2026-05-08
Roth Capital
Top 30%
71
Strong BuyReiterates$212.00+116.66%2026-04-17
Barclays
Top 18%
83
Strong BuyMaintains$237.00+142.21%2026-04-01Find out why
Morgan Stanley
Top 18%
83
Strong BuyUpgrades$212.00+116.66%2026-03-30Find out why
HC Wainwright & Co.
Top 18%
83
BuyMaintains$245.00+150.38%2026-03-26
Mizuho
Top 8%
93
BuyMaintains$206.00+110.53%2026-03-25

1 of 2

Forecast return on equity

Is INSM forecast to generate an efficient return?

Company
217.06%
Industry
95.51%
Market
175.55%
INSM's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is INSM forecast to generate an efficient return on assets?

Company
73.7%
Industry
28.06%
INSM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

INSM earnings per share forecast

What is INSM's earnings per share in the next 3 years based on estimates from 24 analysts?

Avg 1 year Forecast
-$2.77
Avg 2 year Forecast
$0.46
Avg 3 year Forecast
$3.80

INSM revenue forecast

What is INSM's revenue in the next 3 years based on estimates from 24 analysts?

Avg 1 year Forecast
$1.7B+111.33%
Avg 2 year Forecast
$2.9B+249.82%
Avg 3 year Forecast
$4.0B+382.82%
INSM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

INSM revenue growth forecast

How is INSM forecast to perform vs Biotechnology companies and vs the US market?

Company
69.13%
Industry
33.61%
Market
13.79%
INSM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
INSM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

INSM vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
INSM$97.85$212.89+117.57%Strong Buy
ROIV$30.04$36.86+22.69%Strong Buy
INCY$108.53$107.08-1.34%Buy
BNTX$90.54$128.82+42.28%Strong Buy
MRNA$49.91$47.50-4.83%Hold
View Top Biotech Stocks

Insmed Stock Forecast FAQ

Is Insmed Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 18 Wall Street analysts covering (NASDAQ: INSM) stock is to Strong Buy INSM stock.

Out of 18 analysts, 14 (77.78%) are recommending INSM as a Strong Buy, 4 (22.22%) are recommending INSM as a Buy, 0 (0%) are recommending INSM as a Hold, 0 (0%) are recommending INSM as a Sell, and 0 (0%) are recommending INSM as a Strong Sell.

If you're new to stock investing, here's how to buy Insmed stock.

What is INSM's earnings growth forecast for 2026-2028?

(NASDAQ: INSM) Insmed's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 16.2%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.65%.

Insmed's earnings in 2026 is -$1,183,755,000.On average, 24 Wall Street analysts forecast INSM's earnings for 2026 to be -$600,837,794, with the lowest INSM earnings forecast at -$911,270,654, and the highest INSM earnings forecast at -$425,593,438. On average, 24 Wall Street analysts forecast INSM's earnings for 2027 to be $100,313,034, with the lowest INSM earnings forecast at -$206,044,880, and the highest INSM earnings forecast at $373,247,721.

In 2028, INSM is forecast to generate $822,792,304 in earnings, with the lowest earnings forecast at $310,129,407 and the highest earnings forecast at $1,499,818,585.

What is INSM's revenue growth forecast for 2026-2028?

(NASDAQ: INSM) Insmed's forecast annual revenue growth rate of 69.13% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 33.61%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.79%.

Insmed's revenue in 2026 is $819,564,000.On average, 24 Wall Street analysts forecast INSM's revenue for 2026 to be $375,415,245,132, with the lowest INSM revenue forecast at $341,818,615,227, and the highest INSM revenue forecast at $402,942,806,409. On average, 24 Wall Street analysts forecast INSM's revenue for 2027 to be $621,429,277,017, with the lowest INSM revenue forecast at $466,017,769,650, and the highest INSM revenue forecast at $751,263,995,166.

In 2028, INSM is forecast to generate $857,689,448,607 in revenue, with the lowest revenue forecast at $672,149,350,551 and the highest revenue forecast at $1,134,699,080,985.

What is INSM's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: INSM) forecast ROA is 73.7%, which is higher than the forecast US Biotechnology industry average of 28.06%.

What is INSM's Price Target?

According to 18 Wall Street analysts that have issued a 1 year INSM price target, the average INSM price target is $212.89, with the highest INSM stock price forecast at $245.00 and the lowest INSM stock price forecast at $160.00.

On average, Wall Street analysts predict that Insmed's share price could reach $212.89 by Jun 8, 2027. The average Insmed stock price prediction forecasts a potential upside of 117.57% from the current INSM share price of $97.85.

What is INSM's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: INSM) Insmed's current Earnings Per Share (EPS) is -$5.74. On average, analysts forecast that INSM's EPS will be -$2.77 for 2026, with the lowest EPS forecast at -$4.20, and the highest EPS forecast at -$1.96. On average, analysts forecast that INSM's EPS will be $0.46 for 2027, with the lowest EPS forecast at -$0.95, and the highest EPS forecast at $1.72. In 2028, INSM's EPS is forecast to hit $3.80 (min: $1.43, max: $6.92).

What is INSM's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: INSM) forecast ROE is 217.06%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.